Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for types III collagens
Most Correlated Studies
- OMIM - Congenital disorder
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
Most Relevant Literature
- Plasma levels of PRO-C3, a type III collagen synthesis marker, are associated with arterial stiffnes…
- Study on the Effect of Type III Recombinant Humanized Collagen on Human Vascular Endothelial Cells.
- Recombination humanized type III collagen promotes oral ulcer healing.
- Recombinant Human Collagen Type III Improves Hypertrophic Scarring by Regulating the Ratio of Type I…
- Unique Biomarkers of Collagen Type III Remodeling Reflect Different Information Regarding Pathologic…
Most Relevant Clinical Trials
- A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type II…
- Patient Perception and Clinical Efficacy of a Collagen Matrix for the Treatment of Peri-implantitis
- Study Evaluating the Treatment of Forehead and/or Glabellar Lines With the CRYO-TOUCH III Device
- Simultaneous TransPRK and Corneal Collagen Cross-Linking
- Perforated Collagen Membrane With Nanohydroxyapatite for Intrabony Defects
